Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.5.4 updated from v3.5.3, indicating a minor update to the page’s revision history. It does not modify the study details, eligibility criteria, or outcome measures.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page now displays the updated system revision: v3.5.3, replacing the previous v3.5.2. This reflects a routine platform release rather than a change to study content or user-facing features.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision has been updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no substantive study content changes are evident.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision: v3.4.2 was added, and a notice about government funding was removed along with Revision: v3.4.1. These are administrative updates that do not affect study details or outcomes.SummaryDifference0.5%

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.